GlassScriptPhysician profile
Elizabeth Williams
NPI 1528321924
$2,083.23
in general payments reported to CMS, 2019-2025
19 companies · $87.52 in 2025
The $87.52 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $31.88 · 2021: $375 · 2022: $549 · 2023: $429 · 2024: $199 · 2025: $87.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $909.80 | 2019-2025 | Rinvoq, Mavyret, Skyrizi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $333.91 | 2019-2023 | Xifaxan |
| Boston Scientific Corporation | $134.57 | 2022 | |
| Janssen Biotech, INC. | $114.41 | 2020-2023 | Simponi Aria, Simponi, Stelara |
| Braintree Laboratories, INC. | $99.92 | 2019-2022 | |
| Romark Laboratories, Lc | $83.53 | 2019 | |
| Janssen Pharmaceuticals, INC | $79.22 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.65 | 2019-2022 | |
| Qol Medical, LLC | $55.04 | 2019-2021 | |
| Pfizer INC. | $33.18 | 2019 | |
| Merck Sharp & Dohme LLC | $31.22 | 2022 | |
| Organon LLC | $24.67 | 2024 | |
| Olympus America INC. | $24.00 | 2024 | Endoclot Phs |
| Ferring Pharmaceuticals INC. | $17.50 | 2019 | |
| Capsovision, INC. | $17.49 | 2024 | Capsocam Plus |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $17.26 | 2019 | |
| Alfasigma USA, INC. | $14.49 | 2021 | |
| Novo Nordisk INC | $11.76 | 2021 | |
| Endo Pharmaceuticals INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.